(1) |
Stanisstreet M, Herbert LC, Pharoah POD. Effects of thyroid antagonists
on rat embryos cultured in vitro. Teratology 1990; 41: 721-9. |
(2) |
Momotani N, Ito K, Hamada N, et al. Maternal hyperthyroidism
and congenital malformation in the offspring. Clin Endocrinol 1984; 20:
695-700. |
(3) |
Stanisstreet M, Pharoah POD, Herbert LC. Culture of rat embryos in sera
from human hyperthyroid subjects. Med Sci Res 1988; 16: 1105-6. |
(4) |
Harakawa S, Akazawa S, Akazawa M, et al. Changes of serum thyroid hormone
levels induce malformations on early embryogenesis in rats. Acta Endocrinol
(Copenh) 1989; 121: 739-43. |
(5) |
Sparre LS. Maternal free thyroxine and thyroxine-binding globulin during
pregnancy ending in congenital malformations in the offspring. Gynecol Obstet
Invest 1989; 27: 19-21. |
(6) |
Glinoer D, Lemone M. Goiter and pregnancy: A new insight into and old
problem. Thyroid 1992; 2: 65-70. |
(7) |
Gardner DF, Cruikshank DP, Hays PM, et al. Pharmacology of propylthiouracil
(PTU) in pregnant hyperthyroid women: correlation of matemal PTU concentrations
with cord serum thyroid function tests. J Clin Endocrinol Metab 1986; 62:
217-20. |
(8) |
Momotani N, Noh J, Oyanagi H, et al. Antithyroid drug therapy for Graves'
disease during pregnancy. Optimal regimen for fetal thyroid status. N Engl
J Med 1986; 315: 24-8. |
(9) |
Momotani N, Noh JY, Ishikawa N, et al. Effects of propylthiouracil and
methimazole on fetal thyroid status in mothers with Graves' hyperthyroidism.
J Clin Endocrinol Metab 1997; 82: 3633-6. |
(10) |
Dussault JH. Neonatal screening for congenital hypothyToidism. Clin Lab
Med 1993; 13: 645-52. |
(11) |
Delange F. Neonatal screening for congenital hypothyroidism: results and
perspectives. Horrn Res 1997; 48: 51-61. |
(12) |
McCaroll AM, Hutchinson M, McAuley R, et al. Long terrn assessment of
children exposed in utero to carbimazole. Arch Dis Child 1976; 51: 532-6. |
(13) |
Burrow GN, Klatskin EH, Genel M. Intellectual development in children
whose mothers received propylt, hiouracil during pregnancy. Yale J Bio]
Med 1978; 51: 151-6. |
(14) |
Messer PM, Hauffa BP, Olbricht T, et al. Antithyroid drug treatment of
Graves' disease in pregnancy: Iong-term effects on somatic growth, intellectual
development and thyroid function of the offspring. Acta Endocrinol (Copenh)
1990; 123: 311-6. |
(15) |
Eisenstein Z, Weiss M, Katz Y, et al. Intellectual capacity of subjects
exposed to methimazole or propylthiouracil in utero. Eur J Pediatr 1992;
151: 558-9. |
(16) |
Refetoff S, Ochi Y, Selenkow HA, et aL Neonat.al hypothyroidism and goiter
in one infant of each of two sets of twins due to meternal therapy with
antithyroid drugs. J Pediatr 1974; 85: 240-4. |
(17) |
Robinson PL, O'Mullane NH, Aldernam B. Pr'e_na. tal t, rea.tment of fetal
t.hyrotoxicosis. BMJ 1979; 1: 383-4. |
(18) |
Cove DH, Johnston P. Fetal hyperthyroidism. Experience of treatment in
four siblings. Lancet 1985; 1: 430-2. |
(19) |
Momotani N, Hisaoka T, Noh J, et al. Effects of io. dine on thyroid status
of fetus versus mot,her in treatment of Graves' disease complicated by pregnancy.
J Clin Endocrinol Metab 1992; 75: 738-44. |